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Highlights 21 
 A synthetic peptide ELISA was developed for detecting SRLV infection. 22 
 Sheep were experimentally infected with genotype A and B SRLV. 23 
 Serological detection was improved, compared with standard methods. 24 
 Combining epitopes from different genotypes improve ELISA sensitivity. 25 
 26 
Abstract 27 
The major challenges in diagnosing small ruminant lentivirus (SRLV) infection include early 28 
detection and genotyping of strains of epidemiological interest. A longitudinal study was carried out 29 
in Rasa Aragonesa sheep experimentally infected with viral strains of genotypes A or B from Spanish 30 
neurological and arthritic SRLV outbreaks, respectively. Sera were tested with two commercial 31 
ELISAs, three based on specific peptides and a novel combined peptide ELISA. Three different PCR 32 
assays were used to further assess infection status. 33 
 34 
The kinetics of anti-viral antibody responses were variable, with early diagnosis dependent 35 
on the type of ELISA used. Peptide epitopes of SRLV genotypes A and B combined in the same well 36 
enhanced the overall detection rate, whereas single peptides were useful for genotyping the 37 
infecting strain (A vs. B). The results of the study suggest that a combined peptide ELISA can be used 38 
for serological diagnosis of SRLV infection, with single peptide ELISAs useful for subsequent 39 
serotyping. 40 
 41 
Keywords: Small ruminant lentivirus; Genotype; Serology; Peptide ELISA 42 
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Introduction 44 
Small ruminant lentiviruses (SRLV), including Visna/Maedi virus (VMV) and caprine arthritis-45 
encephalitis virus (CAEV) are widely distributed in sheep and goats. Since no treatment or effective 46 
vaccines are available, the control of SRLV infection is based on early diagnosis and culling of 47 
infected animals and their progeny. Infected animals often show decreased milk production and 48 
quality due to increased somatic cell counts and shortened lactation periods (Turin et al., 2005; 49 
Martinez-Navalon et al., 2013). 50 
 51 
Use of PCR allows early diagnosis, genotyping and quantification of viral DNA (Gonzalez et 52 
al., 2005; Herrmann-Hoesing et al., 2007; Brinkhof et al., 2008; Leginagoikoa et al., 2009), but is 53 
mainly employed as a confirmatory test or for research purposes as viral genetic heterogeneity and 54 
low viral load limit the use of PCR as a commercial diagnostic assay. Diagnosis of SRLV infection is 55 
currently undertaken by serological methods, with agar gel immunodiffusion (AGID) being 56 
increasingly replaced by ELISA as a result of its increased sensitivity, objectivity and automation. 57 
Indirect and competition ELISAs, based on a monovalent design, have been widely applied for 58 
diagnosis of SRLV infection (de Andres et al., 2005; Herrmann-Hoesing, 2010; Muz et al., 2013; 59 
Ramirez et al., 2013; Santry et al., 2013; Tolari et al., 2013), and in SRLV eradication programmes 60 
(Brinkhof et al., 2010; Herrmann-Hoesing, 2010; Perez et al., 2010; 2013). However, their use has 61 
been hindered by unexpected seroconversion (Cardinaux et al., 2013; Ritchie and Hosie, 2014), 62 
suggesting that ELISAs need to be designed to cover a greater antigenic range in order to counter 63 
SRLV genetic heterogeneity (Grego et al., 2002; de Andres et al., 2013). 64 
 65 
Five SRLV genotypes (A–E) have been identified to date. Genotypes A and B include VMV-like 66 
and CAEV-like strains, respectively, which are common among SRLV infections across the world and 67 
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which have been identified in Spanish neurological and arthritic outbreaks (Glaria et al., 2009; 2012). 68 
Genotype C has been reported in sheep and goats from Norway (Gjerset et al., 2006) and genotype E 69 
has been found in goats from particular regions of Italy (Grego et al., 2007; Reina et al., 2009). 70 
 71 
Serological testing is usually more sensitive and specific when using homologous rather than 72 
heterologous antigens (Lacerenza et al., 2006). However, genotype A-derived antigens are more 73 
likely to detect cross-reacting antibodies than genotype B- or E-derived antigens (Grego et al., 2005; 74 
Carrozza et al., 2009; Rachid et al., 2013; Tolari et al., 2013). The limitations of current monovalent 75 
serological tests can be explained by the antigenic variation and mutation rate of SRLV, linked to the 76 
appearance of different serotypes (Glaria et al., 2012; Cardinaux et al., 2013). The use of synthetic 77 
peptides might allow bespoke diagnostic tests to be developed that are matched to the specific 78 
epitopes of the viral serotype under investigation (Lacerenza et al., 2006; Mordasini et al., 2006; de 79 
Andres et al., 2013).  80 
 81 
The aim of the present study was to assess a new combined-peptide ELISA (cPE) for 82 
serological diagnosis of infection with SRLV genotypes A and B and to compare results with ELISAs 83 
using individual and combined peptides and with commercially available immunoassays. 84 
 85 
Materials and methods 86 
Viral strains 87 
Two SRLV strains were used, strain 697 (genotype A) from a neurological outbreak (Glaria et 88 
al., 2012) and strain 496 (genotype B) from an arthritic outbreak (Glaria et al., 2009) of SRLV. Strains 89 
697 and 496 were sub-cultured once in blood derived macrophages (BDM) and ovine skin fibroblasts 90 
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(SF), respectively. Strain 496 culture supernatants were titrated by limiting dilution (Reed, 1938), and 91 
those from strain 697 by measuring reverse transcriptase (RT) activity produced in the supernatant 92 
using a commercial kit (HS-Lenti RT activity, Cavidi). Culture supernatants were filtered through a 93 
0.44 µm filter and stored in aliquots containing 106 TCID50/mL at -80 °C until used in experimental 94 
infection. 95 
 96 
Experimental infection and longitudinal sampling 97 
Two-month old castrated male sheep of the Rasa Aragonesa breed (n = 16) were obtained 98 
from accredited SRLV-free flocks (Perez et al., 2010) and housed at the Animal Facilities of the 99 
Veterinary Faculty, University of Zaragoza. All animals were tested periodically by ELISA (Elitest; 100 
Saman et al., 1999) and PCR for 2 months prior to experimental infection. 101 
 102 
Experimental infection was performed by intra-medullary inoculation into the trochanteric 103 
fossa as described previously (Reina et al., 2011). On the day of challenge, sheep were allocated to 104 
one of three groups, each housed separately. Sheep from groups A and B (n = 6 each) were injected 105 
with 1 mL (106 TCID50) of virus containing cell culture supernatant, for strains 697 and 496, 106 
respectively. The control group (group C; n = 4) received 1 mL of sterile filtered cell culture medium. 107 
A second injection was undertaken in the same animals 60 days later, following the same procedure. 108 
 109 
Blood samples in EDTA anticoagulant were collected before inoculation and at weekly 110 
intervals until day 308 (week 44 from the first experimental infection) and separated plasma stored 111 
at -20 °C prior to testing. Peripheral blood leukocytes (PBL), obtained following red blood cell lysis, 112 
were resuspended in PBS and stored at -80 °C until DNA extraction for PCR studies. Sequential 113 
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culling of selected animals (one control and two from each of the infected groups) was carried out at 114 
weeks 21, 35 and 46 post-infection. 115 
 116 
All procedures were carried out under Project License PI09/10 approved by the Ethics 117 
Committee for Animal Experiments (University of Zaragoza). The care and use of animals were 118 
performed accordingly with the Spanish Policy for Animal Protection RD53/2013, which meets the 119 
European Union Directive 2010/63 on the protection of animals used for experimental and other 120 
scientific purposes.  121 
 122 
Commercial ELISAs 123 
Two commercially available ELISAs were used, namely the Elitest-MVV (Hyphen-Biomed), 124 
which is based on p25 recombinant protein and a transmembrane synthetic peptide, both derived 125 
from genotype A (Saman et al., 1999) and AG-Chekit CAEV/MVV (IDEXX Laboratories), based on the 126 
Swiss MVV-OLV whole virus antigen (Zanoni et al., 1994). Both assays were performed according to 127 
the manufacturers’ recommendations. 128 
 129 
Peptide ELISAs 130 
Peptide ELISAs were designed using the synthetic peptides 98M (VDMPQSYIEKQKRNK), 131 
126M1 (ELDCWHYHQYCVTST) and 126M2 (ELDCWHYQHYCVTST), either individually or in 132 
combination (cPE) (de Andres et al., 2013). Peptides were obtained from Thermo Scientific, diluted 133 
in carbonate buffer (pH 9.6) at 1 mg/mL and stored at -20 ºC until use. Peptide 98M is based on a 134 
SU5 consensus sequence among strains identified from the Spanish neurological outbreak. Peptides 135 
126M1 and 126M2, based on the transmembrane region, were identical except for inversion of 136 
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amino acid residues HQ (126M1) or QH (126M2) present in CAEV-like and VMV-like sequences, 137 
respectively. 138 
 139 
Initially, 96-well microplates (Maxisorp, Nunc) were coated with 100 ng of synthetic peptide, 140 
either individually or in equimolar amounts for the cPE and allowed to dry overnight at 37 °C. Plates 141 
were washed with phosphate buffered saline (PBS) supplemented with 0.1% Tween 20 (PBS-T) and 142 
blocked with 2.5% bovine casein (Sigma–Aldrich) for 1 h at 37 °C. Serum samples were diluted 1 in 143 
20 in dilution buffer (PBS containing 1.25% bovine casein) and plates incubated for 1 h at 37 °C. 144 
Peroxidase-conjugated anti-ruminant IgG (EG5; Ingenasa) was added (1/100 in dilution buffer) and 145 
plates incubated for 1 h at 37 °C. One hundred microlitres per well of 2,2'-azino-bis(3-146 
ethylbenzothiazoline-6-sulphonic acid) (ABTS, Millipore) were added as the substrate and the optical 147 
density measured at 405 nm (OD405) after 15–40 min.  148 
 149 
Serum samples were tested alongside positive and negative control sera, included on each 150 
plate. Antibody positive serum was obtained from a naturally infected sheep, whereas negative 151 
control sera came from animals belonging to SRLV-free certified flocks (Pérez et al., 2010). 152 
Absorbance values were calculated by subtracting the negative control OD405 (diluent only, no 153 
peptide) from each sample OD405. Samples with absorbance values >0.3 were considered positive, 154 
based on a threshold value determined previously for sera from uninfected sheep (de Andres et al., 155 
2013). 156 
 157 
Polymerase chain reaction 158 
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Genomic DNA was extracted from PBL using the DNA Blood Mini Kit (Qiagen). PCR was used 159 
to amplify selected regions of the gag gene, yielding amplicons of 510 base pairs (bp) (PCR named 160 
C/O) (Glaria et al., 2009), or 800 bp (PCR named GAG) (Grego et al., 2007) and long terminal repeats 161 
(LTR) of approximately 300 bp (depending on the strain) (Glaria et al., 2009). Each reaction mix 162 
consisted of Reaction Buffer 1× (Biotools), 2 mM MgCl2 (Biotools), 240 µM of each dNTP (Applied 163 
Biosystems), 20 pmol of each primer, 0.02 U/μL of Taq DNA polymerase (Biotools) and 1 µg of 164 
sample DNA to a final volume of 25–50 μL. PCR consisted of 45 cycles of denaturation at 95 ºC for 1 165 
min, annealing (55–60 ºC) for 1 min and elongation at 72 ºC for 1 min/Kb of amplified DNA, followed 166 
by a final elongation step at 72 ºC for 10 min. 167 
 168 
Since SRLV strains 697 and 496 differed by 21 and 23 bp in C/O and LTR amplicons, 169 
respectively, PCR products from test samples were subjected to agarose gel electrophoresis 170 
alongside DNA amplified from cells infected in vitro with strains 697 or 496. Using this internal 171 
control, the viral strain, infecting each animal, could be identified. To identify viral mutations, four 172 
GAG amplicons of each strain, obtained at the end of the study, were purified with a PCR extraction 173 
kit (ATP Biotech), cloned into the pGEM-T easy vector (Promega) and submitted for sequencing 174 
(StabVida). 175 
 176 
Results 177 
PCR analysis 178 
PCR results confirmed that samples from group C, the mock-inoculated sheep, were negative 179 
for virus (data not shown) and that the experimental procedure was successful, in terms of the 180 
infection status of animals in groups A and B. The identity of the viral strain present in infected 181 
animals was verified by analysing the PCR amplicon length, that differed between strains 496 and 182 
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697 by 21 and 23 bp in C/O and LTR PCRs, respectively, and by direct sequencing of GAG amplicons, 183 
performed with samples from each infected group, taken 44 weeks post infection (see Appendix: 184 
Supplementary material).  185 
 186 
Gag sequences from strain 496-infected animals, obtained at the end of the study period, 187 
showed nucleotide differences of 1.27% (i.e. 10 base changes in 787 nucleotides). These mutations 188 
were all synonymous changes except one, G381E in the gag p55 polyprotein. Sequences from strain 189 
697-infected animals showed nucleotide differences in gag of 2.85% (22 base changes in 772 190 
nucleotides) with non-synonymous mutations located at A310T, _421InsK, T428N and K429G, all of 191 
which were downstream of the reported p25 immunogenic regions and upstream immunogenic 192 
epitopes described in p14 (Lacerenza et al., 2008). 193 
 194 
Evidence of infection was seen within the first month of exposure, although PCR reactivity 195 
subsequently fluctuated during the study period (Table 1). Use of GAG primers in PCR showed the 196 
greatest number of positives, with all of the 496-infected animals and all but one of the 697-infected 197 
animals PCR positive by week 28. Nine weeks after the first experimental infection, PCR was most 198 
likely to detect infection by strain 496 (Table 1). In contrast, the LTR PCR detected the least number 199 
of positives, particularly in animals exposed to the 697 strain. After the second challenge, these 200 
differences in performance of the PCRs were maintained, with the exception of results in weeks 9 201 
and 16 (Table 1). 202 
 203 
Serological analysis 204 
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None of the samples from the control group (n = 4) were found to be positive by ELISA 205 
during the study period (Table 2). In contrast, all the SRLV-inoculated animals (n = 12) showed 206 
positive results in at least one of the ELISAs and/or PCRs. As expected from the peptide sequence 207 
(based on genotype A), the monovalent 98M peptide ELISA only detected those animals exposed to 208 
the 697 strain (Table 2). The ELISA using peptide 126M1 (based on genotype B) identified those 209 
animals exposed to the 496 strain, although not exclusively, as one of the animals exposed to the 210 
697 strain also tested positive on two occasions (Table 2). Peptide 126M2 was designed on the SRLV 211 
genotype A sequence, but the ELISA detected exposure to genotype B (strain 496) in more animals 212 
than those exposed to genotype A (strain 697), although in decreased proportions compared to 213 
using the 98M or 126M1 ELISAs for detecting exposure to genotype A and B, respectively. Thus, in 214 
monovalent ELISAs, peptides 98M and 126M1 could detect exposure to a particular genotype (A vs. 215 
B, respectively), but were unable (98M) or inefficient (126M1) for detecting both types of infection. 216 
 217 
A relatively low proportion of animals showed evidence of seroconversion by cPE, Elitest or 218 
Chekit up to 7 weeks post-infection with the two SRLV strains (Fig. 1). Genotype-A specific antibodies 219 
were detected by cPE after this period in more animals and at more time points compared to the 220 
commercial ELISAs. Chekit, Elitest and cPE preferentially detected infection with strain 496 221 
(genotype B) compared with strain 697 (genotype A). In most cases, cPE results were the same as 222 
the combined results of the monovalent peptide ELISAs, with one exception at week 11, where one 223 
animal exposed to the 697 strain was positive in the 98M peptide ELISA but negative in the cPE 224 
(Table 2). The study results indicate that the cPE was able to detect exposure to genotype A and B of 225 
SRLV early after challenge and efficiently throughout the study period. 226 
 227 
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 The kinetics of the antibody response, based on use of cPE, Elitest or Chekit are summarized 228 
in Fig. 1. ELISA absorbance values of uninfected animals remained below the threshold in the three 229 
ELISA tested. Seroconversion in animals exposed to the 496 strain was detected early after 230 
inoculation and at sampling times thereafter in cPE and Chekit (Fig. 1D, F). In contrast, exposure to 231 
the 697 strain was only successfully detected serologically using the cPE, likely due to incorporation 232 
of peptide 98M (Fig. 1A). Elitest detected relatively few animals exposed to either SRLV genotype 233 
(Fig. 1B, E). 234 
 235 
Discussion 236 
Decreased prevalence and improved control of SRLV infection has been achieved using 237 
serological testing based on the use of ELISAs (Scheer-Czechowski et al., 2000; Christodoulopoulos, 238 
2006; Brinkhof et al., 2010; Perez et al., 2013). In addition, conventional and real time PCRs have 239 
been designed for broad and specific detection of SRLV, even in seronegative animals (Brajon et al., 240 
2012; Kuhar et al., 2013). Recently, alternative methods, based on identifying the TMEM154 gene, 241 
have been proposed to classify susceptible/resistant SRLV sheep populations (Leymaster et al., 2013; 242 
Sider et al., 2013). 243 
 244 
Despite advances in diagnostic techniques, genetic variability and antigenic variation of SRLV 245 
can lead to failure to detect all infections (Cardinaux et al., 2013; de Andres et al., 2013). In the 246 
present study, we performed a serological survey of animals experimentally infected with Spanish 247 
SRLV strains 697 and 496, assessing the performance of a new multivalent ELISA (cPE), based on the 248 
use of a combination of synthetic peptides, comparing its performance alongside monovalent 249 
peptide ELISAs and two commercially available ELISAs. 250 
 251 
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All but one of the animals that were experimentally challenged with SRLV strains 496 and 252 
697 became PCR positive on at least one occasion during the study period. PCR identified infected 253 
animals, albeit in small proportions within the first month post-challenge in the strain 697-infected 254 
group, but in increased proportions during the experimental period, confirming the utility of PCR as 255 
a diagnostic tool. However, PCR results fluctuated over time, representing a drawback for field 256 
diagnosis of SRLV infections where often a single sample is assessed. Variability in the PCR assay to 257 
detect virus in infected animals might have been related to mutations affecting the primer binding 258 
sites. Although, gag sequencing at the end of the study revealed some mutations, particularly in the 259 
animals exposed to the 697 strain, none of these were located at primer binding sites. 260 
 261 
Our study shows the benefits of the cPE for detecting SRLV infections and the use of 262 
individual peptides to genotype the infecting virus. These observations are consistent with our 263 
previous field studies on the diagnosis of subclinical and clinical infections using a combination of 264 
single peptide ELISAs (Glaria et al., 2012; de Andres et al., 2013), where use of the 98M peptide was 265 
genotype A specific, whereas the capacity of peptides 126M1 and 126M2 differed in their specificity 266 
(de Andres et al., 2013). As expected, strain 496 (genotype B) infections were preferably detected by 267 
peptide 126M1, cPE and Chekit ELISAs. The relatively low detection rate by Chekit in genotype A-268 
infected animals was unexpected, as this assay is based on use of whole virus antigen that would be 269 
expected to recognise cross-reacting antibodies. The single amino acid inversion in the TM peptides 270 
employed led to a change in antibody profile, confirming previous observations (de Andres et al., 271 
2013). This difference became most evident by week 20 and indicates the diagnostic value of these 272 
peptides in detecting VMV-like or CAEV-like infections, as reported in clinical outbreaks (Glaria et al., 273 
2009).  274 
 275 
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Elitest, based on genotype-A derived antigens, detected seropositive animals infected with 276 
the 496 strain by week 28, most likely because some of the epitopes were binding cross-reactive 277 
antibodies. This is in agreement with the general trend of genotype A-derived antigens to better 278 
detect cross-reacting antibodies compared with genotype B-derived antigens (Gogolewski et al., 279 
1985; Lacerenza et al., 2006; Carrozza et al., 2009). However, the low proportion of positive animals 280 
detected by Elitest was unexpected (only 1/6 animals at week 20 in the experimental group infected 281 
with genotype A) particularly in the light of the greater number in this group with positive test 282 
results using the other ELISAs containing type A antigens (cPE and 98M). This low Elitest detection 283 
rate in the animals infected with strain 697 was not due to failures in experimental procedure, since 284 
PCR confirmed infection with each genotype in both groups.  285 
 286 
The lower proportion of seropositive animals in the 697 strain-infected group, as compared 287 
with those infected with the 496 strain, might be related to differences in viral loads. Quantitative 288 
PCR, performed in target tissues has revealed increased proviral loads in animals infected with the 289 
496 strain (unpublished data). Consistent with this observation, replication dynamics, according to 290 
the proportion of PCR-positive results, indicated an advantage for strain 496 relative to strain 697 on 291 
the different test dates (except at the beginning of the study). Viral load differences may have been 292 
caused by strain differences in replication dynamics in vivo, in agreement with strain differences 293 
previously found in vitro, with phenotypes rapid/high vs. slow/low for strains 496 and 697, 294 
respectively (Glaria et al., 2009; 2012). Alternatively, a breed effect may be involved, such that strain 295 
697 infection might have increased replication and pathogenicity in the Assaf breed (Benavides et 296 
al., 2006) but not in the Rasa Aragonesa breed used in the present study. 297 
 298 
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The introduced mutations found in both SRLV genomes during the course of the infection 299 
period, although mainly synonymous, may have affected the host-pathogen interaction or infection 300 
dynamics and might have been responsible for an attenuated phenotype and decreased antibody 301 
response in 697 strain-infected sheep. Alternatively, the differences in viral titration methods used 302 
for both strains may have led to an overestimation of the 697 virus titre and thus injection of 303 
relatively less virus for experimental infection, explaining the decreased serological reactivity found 304 
in group A sheep. 305 
 306 
Use of synthetic peptides from different SRLV genotypes, combined in the same ELISA well, 307 
improved detection of early and late stages of infection, compared with the use of commercially 308 
available ELISAs. Those same peptides used individually, were able to identify the specific SRLV 309 
genotype involved in the infection. It is important that the antigens used in serological testing are 310 
reviewed periodically and revised to ensure that they match the antigenic profile of the target virus. 311 
This is particularly important for those viruses that undergo antigenic shift and drift. Updated ELISAs 312 
may be required to diagnose infections by emerging SRLV strains in order to achieve early diagnosis 313 
and improved sensitivity for SRLV control programs. Use of synthetic peptides is particularly suited 314 
to this strategy as additional antigenic epitopes can be added to the ELISA relatively quickly and cost-315 
effectively. 316 
 317 
Conclusions 318 
ELISAs can be used for serological testing of animals exposed to different SRLV genotypes. 319 
Phylogenetic and epidemiological data should be employed to select peptide epitopes for use in 320 
ELISAs that are capable of detecting antibodies generated following exposure to SRLV. Genotype-321 
specific diagnosis of SRLV infection is possible with specific synthetic peptides in ELISA testing. In 322 
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addition, a combination of peptides in the same ELISA well broadens the specificity and facilitates 323 
detection of divergent SRLV strains. 324 
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Figure Legend 
Fig. 1. Kinetics of antibody responses in sheep after experimental infection, based on ELISA testing. Top panels (A, B and C): ELISA absorbance values (minus 
background) obtained with the combined peptide ELISA (cPE), Elitest or Chekit, respectively, in animals infected with strain 697 (genotype A) (continuous 
lines). Bottom panels (D, E and F): ELISA absorbance values (minus background) obtained with cPE, Elitest or Chekit ELISAs in animals infected with strain 
496 (genotype B) (continuous lines). Animals were injected with virus on weeks 0 and 8. Results from the mock inoculated control animals (C1-C4) are also 
included in the graphs (dashed lines). Date of sequential culling is indicated by interruption of the line. 
 
Table 1 
Proportion of positive sheep in LTR, C/O and GAG PCR assays, considering results individually and in combination, at 
different time points, following challenge with  small ruminant lentivirus (SRLV) strains 697 or 496. 
 
 
Week post 
challenge 
 
 
 
SRLV strain 
 
Individual PCRs 
LTR C/O GAG  Combined PCR 
result  
4 697  0/6 1/6 0/6  1/6 
 496  0/6 0/6 0/6  0/6 
        
9 697  1/6 1/6 1/6  2/6 
 496  4/6 4/6 2/6  4/6 
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16 697  0/6 2/6 3/6  4/6 
 496  3/6 0/6 5/6  5/6 
        
28 697  0/4 1/4 2/4  2/4 
 496  2/4 3/4 4/4  4/4 
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Table 2 
Serological response of control (n = 4) and infected (n = 6 per group) sheep at different time points following challenge with SRLV strains 697 or 496, 
assessed by the monovalent (98M, 126M1 or 126M2) and the combined peptide ELISAs (cPE). Symbols correspond to Fig. 1. Blank  
spaces indicate culled animals. 
 
Comment [A1]: PRE-EDITOR: Table 2 for 
rekey. 
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Appendix 
 
Supplementary material 
Alignment of deduced protein sequences obtained at 44 weeks post-infection with SRLV strain 496 
(A) or 697 (B). Reference sequence is Ov496 (GenBank: FJ195346.1). An example of three 
independent clones from each experimental infection is shown. 
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